Clinical trial · Interventional
Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care
A Randomized Controlled Clinical Study on Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Enhanced recovery after surgery (ERAS) is a strategy of perioperative management aimed to accelerate the rehabilitation of patients through various optimized perioperative managements as well as ongoing adherence to a patient-focused, multidisciplinary, and multimodal approach. Alleviating the injury and stress caused by surgery or disease is the core principle of ERAS, which has been shown to reduce complication rates after surgery, promote patient recovery, decrease hospital length of stay and reduce costs. ERAS has been widely applied in many surgical perioperative fields, and it has achieved remarkable effects. However, there are few applications of ERAS in neurosurgery, especially in clinical trials of neurocritical care patients. Therefore, the investigators attempt to conduct the study of ERAS in neurosurgical intensive patients using a series of optimized perioperative managements that have been verified to be effective by evidence-based medicine, and to evaluate the safety and effectiveness of ERAS in neurocritical care. The aim of this study is to explore the most suitable ERAS protocols to accelerate the postoperative rehabilitation process of neurocritical care patients, and to provide more evidence-based medicine for the effectiveness and safety of ERAS in neurosurgery.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cerebrovascular Disease | — | UNRESOLVED | — |
| Moderate or Severe Coma | — | UNRESOLVED | — |
| Neurocritical Care | — | UNRESOLVED | — |
| Traumatic Brain Injury | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Conventional therapy | Procedure | — | UNRESOLVED |
| Enhanced recovery after surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Enhanced recovery after surgery
- description
- The technologies, processes and measures of enhanced recovery after surgery were applied.
- interventionNames
- Procedure: Enhanced recovery after surgery
- type
- ACTIVE_COMPARATOR
- label
- Conventional therapy
- description
- Conventional therapy were applied.
- interventionNames
- Procedure: Conventional therapy
Primary outcomes (2)
- measure
- Clinical prognosis
- timeFrame
- One month, three and six months after injury or attack
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18-75 years old * Patients with moderate or severe acute traumatic brain injury or cerebrovascular disease requiring neurosurgical intensive care treatment * Hospitalization time ≥ 1 week * The guardian is able to understand and actively cooperate in completing the project * The guardian signs an informed consent form Exclusion Criteria: * Patients undergoing non-surgical treatment * Patients diagnosed as brain death within the first 24 hours after admission to NICU * Patients undergoing cardiopulmonary resuscitation, maintenance dialysis, end-stage tumors, and disseminated cancer * Patients who withdraw treatment during hospitalization or are discharged automatically * Patients who underwent unplanned secondary surgery during the research process * Individuals who cannot be followed up during the research process
References
Publications (0)
Data not yet available